Search research articles
Contact Us
Filters
Showing results (121-130 of 199) with videos related to
Page
of 20
Sort By:
British Journal of Haematology
|
September 4, 2024
Efficacy and safety of daratumumab in multiresistant immune-mediated thrombotic thrombocytopenic purpura
Julia Weisinger, Raïda Bouzid, Dana Ranta, et al.
The Lancet. Haematology
|
May 3, 2016
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy
Eric Mariotte, Elie Azoulay, Lionel Galicier, et al.
Oncogene
|
June 25, 2003
Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells
Paul Coppo, Isabelle Dusanter-Fourt, Gael Millot, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 7, 2019
Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study
Paul Knoebl, Spero Cataland, Flora Peyvandi, et al.
Plos One
|
May 26, 2017
Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome
Matthieu Jamme, Quentin Raimbourg, Dominique Chauveau, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 11, 2020
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
X Long Zheng, Sara K Vesely, Spero R Cataland, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 11, 2020
Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura
X Long Zheng, Sara K Vesely, Spero R Cataland, et al.
Clinical Hematology International
|
January 7, 2025
Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective study
Nicolas Stocker, Tamim Alsuliman, Elise Corre, et al.
Haematologica
|
December 8, 2018
Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients
An-Sofie Schelpe, Elien Roose, Bérangère S Joly, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 11, 2020
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura
X Long Zheng, Sara K Vesely, Spero R Cataland, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 199) with videos related to
Sort By:
Page
of 20
British Journal of Haematology
|
September 4, 2024
Efficacy and safety of daratumumab in multiresistant immune-mediated thrombotic thrombocytopenic purpura
Julia Weisinger, Raïda Bouzid, Dana Ranta, et al.
The Lancet. Haematology
|
May 3, 2016
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy
Eric Mariotte, Elie Azoulay, Lionel Galicier, et al.
Oncogene
|
June 25, 2003
Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells
Paul Coppo, Isabelle Dusanter-Fourt, Gael Millot, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 7, 2019
Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study
Paul Knoebl, Spero Cataland, Flora Peyvandi, et al.
Plos One
|
May 26, 2017
Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome
Matthieu Jamme, Quentin Raimbourg, Dominique Chauveau, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 11, 2020
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
X Long Zheng, Sara K Vesely, Spero R Cataland, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 11, 2020
Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura
X Long Zheng, Sara K Vesely, Spero R Cataland, et al.
Clinical Hematology International
|
January 7, 2025
Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective study
Nicolas Stocker, Tamim Alsuliman, Elise Corre, et al.
Haematologica
|
December 8, 2018
Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients
An-Sofie Schelpe, Elien Roose, Bérangère S Joly, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 11, 2020
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura
X Long Zheng, Sara K Vesely, Spero R Cataland, et al.
Page
of 20